Detail of the session
Type :
FOCUS SESSION 1
FOCUS SESSION 1
Date :
Thursday 25th April 2019
Thursday 25th April 2019
Schedule :
16h30 - 18h00
16h30 - 18h00
Session Title :
FS01 - Focus Session 1: Epidemiology and Registries
O011
16h30 - 16h45
16h30 - 16h45
Registries in dermatology: strengths and learning points
Phyllis SPULS - Netherlands
Phyllis SPULS - Netherlands
O012
16h45 - 17h00
16h45 - 17h00
Epidemiology of major inflammatory skin diseases anno 2019
Luigi NALDI - Italy
Luigi NALDI - Italy
O013
17h00 - 17h15
17h00 - 17h15
Epidemiology of major inflammatory skin diseases in emerging countries
Alur KUMAR - India
Alur KUMAR - India
O014
17h15 - 17h30
17h15 - 17h30
Comorbidity occurrence in major inflammatory skin diseases
Alexander EGEBERG - Denmark
Alexander EGEBERG - Denmark
P001
17h30 - 17h35
17h30 - 17h35
SAFETY EVENTS OCCURRING AMONG PATIENTS EXPOSED TO IXEKIZUMAB IN THE CORRONA PSORIASIS REGISTRY
Gaia GALLO - United States
Gaia GALLO - United States
P002
17h35 - 17h40
17h35 - 17h40
NUMBER NEEDED TO TREAT AND COST PER RESPONDER FOR FLEXIBLE ADALIMUMAB DOSING IN THE TREATMENT OF PSORIASIS IN PATIENTS WITH SUBOPTIMAL RESPONSE TO 40MG EVERY OTHER WEEK DOSING
Laura J. SAVAGE - United Kingdom
Laura J. SAVAGE - United Kingdom
P003
17h40 - 17h45
17h40 - 17h45
RESPONSE TO ADALIMUMAB IN PATIENTS WITH PLAQUE PSORIASIS BY ASSOCIATED MANIFESTATIONS: ANALYSES FROM THE BRITISH ASSOCIATION OF DERMATOLOGISTS BIOLOGICS AND IMMUNOMODULATORS REGISTER
Laura J. SAVAGE - United Kingdom
Laura J. SAVAGE - United Kingdom